Screener
Viridian Therapeutics, Inc. VRDN Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$127.12M-26.2% | -$104.9M-20.7% | -$120.36M-51.0% | -$34.6M+54.9% | -$100.74M-55.0% | ||
| $117K+3.5% | $121K+3.4% | $120K-2.4% | $110K-15.4% | $113K-20.4% | ||
| $16.98M+56.6% | $13.39M+31.0% | $11.99M+33.6% | $11.25M+29.0% | $10.84M-7.8% | ||
| -$105.32M-39.7% | -$119.65M-29.1% | -$23.75M+67.6% | -$84.61M-25.0% | -$75.37M-63.6% | ||
| $1.31M+3,010% | $23K-73.3% | $240K+111% | $127K-56.7% | $42K-59.6% | ||
| -$231.16M-405% | $77.26M-22.8% | -$339.42M-439% | $126.08M+249% | $75.72M— | ||
| —— | —— | $7.22M— | $7.22M— | $7.22M— | ||
| —— | —— | —— | —— | —— | ||
| $325.12M+42,455% | $6.36M-31.0% | $405.91M+1,043% | $10.86M-95.6% | $764K+607% | ||
| -$11.36M-1,124% | -$36.04M-317% | $42.74M+142% | $52.32M-43.5% | $1.11M-93.1% | ||
| -$106.63M-41.4% | -$119.68M-29.0% | -$23.99M+67.3% | -$84.74M-24.6% | -$75.42M-63.4% |
FAQ
- How much cash does Viridian Therapeutics, Inc. generate?
- Viridian Therapeutics, Inc. (VRDN) generated -$333.3M in operating cash flow over the trailing twelve months.
- What is Viridian Therapeutics, Inc.'s free cash flow?
- After $1.7M of capital expenditures, Viridian Therapeutics, Inc.'s free cash flow was -$335.0M over the trailing twelve months, down 8.2% year over year.
- Where does Viridian Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Viridian Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
